Clinical Trial Update: A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin [Phase 1]

View source ↗

Summary

Phase 1 study evaluating systemic absorption of dimebon when applied as a skin solution in participants with Alzheimer's disease or Huntington's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease, Huntington's Disease | Phase 1 | Status: COMPLETED